New Vision Pharmaceuticals Overview

Life ScienceCompany

Is New Vision Pharmaceuticals PE-backed?

Yes. New Vision Pharmaceuticals is owned by private equity investor Morgan Stanley Tactical Value Investing.

Where is New Vision Pharmaceuticals headquartered?

New Vision Pharmaceuticals is headquartered in Tamarac, Florida.

What sector is New Vision Pharmaceuticals in?

New Vision Pharmaceuticals is a life science company.

New Vision Pharmaceuticals

New Vision Pharmaceuticals

10200 NW 67th Street,
Tamarac, Florida 33321
United States,
(954) 721-5000
www.newvisionpharmaceuticals.com

New Vision Pharmaceuticals is a full-service FDA-registered contract development and manufacturing company. New Vision Pharmaceuticals is an experienced and reliable partner with a range of globally sourced raw materials at our disposal. New Vision Pharmaceuticals team of experts has extensive scientific knowledge in the pharmaceutical and dietary supplement industries that allows providing clients with a full range of services. New Vision Pharmaceuticals is based in Tamarac, Florida.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.2/yr) # - 1 - - - - 1
Sell (0.2/yr) # - - 1 - - - 1
  2

Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.